Placeholder Banner

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

“The Biotechnology Innovation Organization welcomes news of the U.S.-China agreement on initial results of the 100-day Action Plan of the U.S.-China Comprehensive Economic Dialogue,” said Joseph Damond, Executive Vice President for International Affairs.  “The agreement marks an important first step in the 100-day plan and towards broader engagement through the newly formed U.S.-China Comprehensive Economic Dialogue.” 

“Considering the history of this issue, the ultimate test of success will be for China to follow its process and quickly approve the eight pending biotechnology applications and establish a synchronized, timely and predictable process going forward,” added Damond.  “BIO will continue to engage through this process to monitor the implementation of the agreement.”  

Discover More
John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…
WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the significant economic impact of the U.S. bioeconomy…